Implicit Racial Bias and Support for Medical Cannabis
Medical Cannabis and Cannabinoids · 2026-11-10
DOI: 10.1159/mca/adoag007 ↗Abstract
Abstract Introduction This study examined whether implicit racial biases influence support for medical cannabis (MC) use (SFMCU) among undergraduate pre-healthcare students and medical cannabis professionals (MCPs). Methods A total of 390 participants (349 students, 41 MCPs) completed a survey of demographic questions, five clinical vignettes with racially randomized patient images, and the Black-White Implicit Association Test (IAT). Student participants were recruited from biology, chemistry, health sciences, nursing, and psychology undergraduate courses at multiple higher educational institutions in Southern California, and a national online university during September and October 2024. MCPs were recruited from a national graduate-level MC student association using snowball sampling. Students (M age = 23; 81% female; 57% Latino) and MCPs (M age = 42; 76% female; 49% Black, 32% White) comprised the sample. Participants rated SFMCU for each hypothetical patient using a 9-point scale. Linear mixed-effects modeling and multiple regression analyses assessed effects of patient race, IAT D-scores, and their interaction on SFMCU. Results Students showed no pro-White bias (M = –0.147) while MCPs showed slight pro-White bias (M = –0.179), but neither implicit bias nor patient race predicted SFMCU. No significant interaction effects were observed. Both groups expressed high support, with MCPs more supportive overall. Discussion Neither patient race nor implicit bias significantly influenced SFMCU. These findings may reflect shifting generational and regional attitudes toward cannabis. While encouraging, the results highlight the need to further examine when and how implicit biases emerge during clinical training and how they may influence support for novel therapeutic interventions such as (MC).
EUVIMED